30 search results
You searched for these word(s): risk assessmentChemical Safety Assessment under REACH, 3-6 July 2018
https://www.rivm.nl/en/agenda/chemical-safety-assessment-under-reach-3-6-july-2018… training provides a full introduction in chemical safety assessment as required in the EU legislation REACH … is organized in close collaboration with Institute for Risk Assessment Sciences (IRAS) Utrecht University. … assessment (day 2 and 3), exposure assessment (day 3), and risk characterization (day 3). During teh course we briefly …
Publication date: 11-02-2018WP 5: Advancement of Regulatory Risk Assessment and Testing
https://www.rivm.nl/en/international-projects/nanoreg/work-package/wp-5-advancement-of-regulatory-risk-assessment-and-testing… SOP 02 Real-time label-free impedance-based nanotoxicity assessment SOP 03 SOP for High Throughput Cell … cell assay for cytokine production D5.08 Decision tree for risk assessment of MNMs 5 RIVM FlowChart NANoREG nanospecific risk assessment strategy D5.09 Summary report WP5 If not …
Publication date: 11-22-2018Children aged 16-18 years at higher risk for medical reasons will receive first vaccination soon
https://www.rivm.nl/en/news/children-aged-16-18-years-at-higher-risk-for-medical-reasons-will-receive-first-vaccination… born in 2003, 2004 and 2005 who are in the medical high-risk group. The first young people in this group will be … These young people are included in the medical high-risk group that the Health Council has defined for adults. … Children aged 16-18 years at higher risk for medical reasons will receive first vaccination soon …
Publication date: 04-19-2021People with a medical risk between the ages of 18-60 years invited from early May on
https://www.rivm.nl/en/news/people-with-medical-risk-between-ages-of-18-60-years-invited-from-early-may-on… in the first week of May, people under 60 who are at risk for medical reasons, i.e. the group eligible for the … in this group are prioritised because they have a higher risk of severe illness from COVID-19. This includes people … to respiratory tract infections. People in the medical high-risk groups already received their invitations for COVID-19 …
Publication date: 04-20-2021NESTI-NEDI
https://www.rivm.nl/en/chemkap/nesti-nedi… Dutch dietary risk assessment models for pesticide authorisation purposes … intake is compared to a toxicological reference value. This risk assessment is a default part of the pesticide authorisation …
Publication date: 11-06-2018New hold on vaccination with AstraZeneca for people under 60 years
https://www.rivm.nl/en/news/new-hold-on-vaccination-with-astrazeneca-for-people-under-60-years… Pharmacovigilance Centre Lareb. The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) is currently investigating this … the investigation are expected on Wednesday, 7 April. A new assessment about the use of AstraZeneca will be made at that … in 1961 or later. For people aged 60 or over, the health risk from contracting COVID-19 is much higher than the risk …
Publication date: 04-02-2021Newsletter on COVID-19 vaccination issue 12 2021
https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/12… Vaccination starts for medical high risk groups … for elderly people and for people in the medical high-risk group due to neurological disorders accompanied by … has been made for four categories in the the medical high-risk groups . This applies to people whose immune system is …
Publication date: 04-02-2021Different vaccine very soon available to people under 60, instead of AstraZeneca
https://www.rivm.nl/en/news/different-vaccine-very-soon-available-to-people-under-60-instead-of-astrazeneca… impact on five groups. This involves people at higher risk for medical reasons who are unable to travel, people … People at higher risk for medical reasons who are unable to travel This …
Publication date: 04-13-2021Newsletter on COVID-19 vaccination issue 15, 2021
https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/15… born in 2003, 2004 and 2005 who are in a medical high-risk group . The first young people in this group will soon … in the first week of May, people under 60 who are at risk for medical reasons , i.e. the group eligible for the … This was the conclusion reached by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines …
Publication date: 04-22-2021Newsletter on COVID-19 vaccination issue 14 2021
https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/14… 60 has a direct impact on five groups: people at higher risk for medical reasons who are unable to travel, people … can be attributed to the vaccine. The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency … in 2003, 2004 and 2005) who are in one of the medical high-risk groups . This vaccine has been approved for people aged …
Publication date: 04-20-2021REACH
https://www.rivm.nl/en/reach… members of Bureau REACH are involved in, for example, the Risk Assessment Committee, the Committee for Socio-economic …
Publication date: 11-06-2018Newsletter on COVID-19 vaccination issue 13 2021
https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/13… This was the conclusion reached by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency …
Publication date: 04-12-2021Fact sheets WP4-WP6
https://www.rivm.nl/en/about-rivm/mission-and-strategy/international-affairs/international-projects/nanoreg/factsheets/fact-sheets-wp4-wp6… methodology to evaluate NM toxicity D5.08 Decision tree for risk assessment of MNMs D6.01 Proposal to monitor innovations … and their applications D6.02 Inventory of safety assessment issues and new approaches to research and …
Publication date: 11-20-2018NANoREG D5.08 FS Flow chart for risk assessment of nanomaterials
https://www.rivm.nl/en/documenten/nanoreg-d508-fs-flow-chart-for-risk-assessment-of-nanomaterials… NANoREG D5.08 FS Flow chart for risk assessment of nanomaterials … NANoREG D5.08 FS Flow chart for risk assessment of nanomaterials …
Publication date: 11-22-2018Fact sheets WP1-WP3
https://www.rivm.nl/en/about-rivm/mission-and-strategy/international-affairs/international-projects/nanoreg/factsheets/fact-sheets-wp1-wp3… D1.08 A summary on the deliverables related to the VCCSs Assessment of value chain case studies Case studies of the … dispersion and transfer D3.09 Data on the effectiveness of risk management measures …
Publication date: 11-20-2018WP 6: Keeping pace with innovation
https://www.rivm.nl/en/international-projects/nanoreg/work-package/wp-6-keeping-pace-with-innovation… and their applications 41 D6.02 Inventory of safety assessment issues and new approaches to research and …
Publication date: 11-22-2018Sewage as an indicator of health
https://www.rivm.nl/en/covid-19/sewage/indicator-health… & Hepatology. SARS-CoV-2 in wastewater: potential health risk, but also data source. Article on …
Publication date: 04-21-2021WP 2: Synthesis, supplying and characterisation
https://www.rivm.nl/en/international-projects/nanoreg/work-package/wp-2-Synthesis-supplying-and-characterisation… content in MNMs by thermogravimetric analysis (TGA) SOP for assessment of the contents of water, organic compounds, and …
Publication date: 11-20-2018NANoREG D3.09 FS Effectiveness of risk management measures
https://www.rivm.nl/en/documenten/nanoreg-d309-fs-effectiveness-of-risk-management-measures… NANoREG D3.09 FS Effectiveness of risk management measures … NANoREG D3.09 FS Effectiveness of risk management measures …
Publication date: 11-20-2018GPs will invite under-60s with Down's syndrome or morbid obesity for GGD vaccination
https://www.rivm.nl/en/news/gps-will-invite-under-60s-with-downs-syndrome-or-morbid-obesity-for-ggd-vaccination… People in these two groups have a higher risk of serious illness from COVID-19. Many of them have … receive their vaccination from week 17 on. Other medical risk groups The other groups at higher risk for medical reasons will be vaccinated via other …
Publication date: 04-16-2021